• 751 static and 225 outreach HIV testing sites
• 732 (static) ART sites; 627 of these started at least one pregnant or breastfeeding woman and 695 started asymptomatic patients (Test & Treat) this quarter
• 655 sites with HIV-exposed children in follow-up

788,275 persons were tested for HIV and received their results; 210,774 (27%) accessed HIV testing for the first time; 577,501 (73 %) were repeat testers and 37,401 (6%) of these received confirmatory testing (after having tested positive in the past). 32,987 (4%) clients received a positive result for the first time.

22,895 (98%) of 23,454 blood units collected were screened for (at least) HIV, hepatitis B and syphilis.

149,150 (97%) of 153,817 women at ANC had their HIV status ascertained; 11,436 (8%) of these were HIV positive. 126,297 (99%) of 129,217 women at maternity had their HIV status ascertained 9,351 (7%) of these were HIV positive.

30,221 patients started ART this quarter; 70% of these were classified as asymptomatic / in WHO stage 1 and started under the new “Test & Treat” policy.

679,056 patients were alive and on ART by end of December 2016. This means that 69% of the estimated 979,000 HIV positive population was on ART. 1 ART coverage was 66% (53,336 / 81,000) for children2 and 70% (625,689 / 898,000) for adults.

47,389 (88%) of 53,886 viral load results from routine monitoring were <1000 copies/ml. Viral suppression rates among children (0-14 years) and adults (15+ years) were 62% and 90%, respectively.

76% of adults and 77% of children were retained alive on ART at 12 months after initiation. Actual retention rates are thought to be about 10% higher due to misclassification of ‘silent transfers’ as defaulters in clinic-based survival/retention analysis. (see section 15.4)

588,620 (93%) of 634,342 patients on first line adult ART were on TDF/3TC/EFV.

11,517 3 (85%) of an estimated 13,500 HIV infected pregnant women in Malawi were on ART this quarter. 7,366 (64%) of these were already on ART when getting pregnant and 4,151 (36%) started ART during pregnancy/delivery.

An additional 1,110 breastfeeding women started ART due to Option B+ (in WHO stage 1/2)

78%, 70%, 63% and 63% of women started under Option B+ were retained on ART at 6, 12, 24 and 36 months after initiation, respectively.

8,646 (7%) of infants discharged alive from maternity were known to be HIV exposed, 8,192 (95%) of these received ARV prophylaxis (nevirapine). 8,297 (96%) were enrolled in exposed child follow-up before age 2 months.

A total of 11,220 HIV exposed children were newly enrolled for follow-up this quarter.